As head of business development at General Electric Co., John Flannery logged more than $26 billion in deals. But such an approach is far from his mind as CEO of the GE's healthcare unit.

Flannery wants to grow from within, even after revenue from diagnostic-imaging machines slowed. The company offers a wide range of products and services, including ventilators, software and tools to support drug manufacturing.

"When we look at the basic position of the company, we like the portfolio," Flannery said in an interview in Beijing. "So my mandate right now is to get the earnings growth going again, and there’s a lot to just better managing the portfolio we have, align it more with customers and outcomes, for a better margin rate."

Read more by following the link below: